These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34624862)

  • 1. 5-Aminolevulinic acid for enhanced surgical visualization of high-grade gliomas: a prospective, multicenter study.
    Schupper AJ; Baron RB; Cheung W; Rodriguez J; Kalkanis SN; Chohan MO; Andersen BJ; Chamoun R; Nahed BV; Zacharia BE; Kennedy J; Moulding HD; Zucker L; Chicoine MR; Olson JJ; Jensen RL; Sherman JH; Zhang X; Price G; Fowkes M; Germano IM; Carter BS; Hadjipanayis CG; Yong RL
    J Neurosurg; 2022 Jun; 136(6):1525-1534. PubMed ID: 34624862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.
    Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW
    J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Aminolevulinic Acid-Shedding Light on Where to Focus.
    Dadario NB; Khatri D; Reichman N; Nwagwu CD; D'Amico RS
    World Neurosurg; 2021 Jun; 150():9-16. PubMed ID: 33684574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
    Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
    J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving contrast enhancement in magnetic resonance imaging using 5-aminolevulinic acid-induced protoporphyrin IX for high-grade gliomas.
    Yamamoto J; Kakeda S; Yoneda T; Ogura SI; Shimajiri S; Tanaka T; Korogi Y; Nishizawa S
    Oncol Lett; 2017 Mar; 13(3):1269-1275. PubMed ID: 28454245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Aminolevulinic acid-enhanced fluorescence-guided treatment of high-grade glioma using angled endoscopic blue light visualization: technical case series with preliminary follow-up.
    Strickland BA; Wedemeyer M; Ruzevick J; Micko A; Shahrestani S; Daneshmand S; Shiroishi MS; Hwang DH; Attenello F; Chen T; Zada G
    J Neurosurg; 2022 Nov; 137(5):1378-1386. PubMed ID: 35303704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.
    Eatz TA; Eichberg DG; Lu VM; Di L; Komotar RJ; Ivan ME
    J Neurooncol; 2022 Jan; 156(2):233-256. PubMed ID: 34989964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
    Chohan MO; Berger MS
    J Neurooncol; 2019 Feb; 141(3):517-522. PubMed ID: 30097823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of 5-ALA fluorescence-guided surgery versus white-light conventional microsurgery for the resection of newly diagnosed glioblastomas (RESECT study): a French multicenter randomized phase III study.
    Picart T; Pallud J; Berthiller J; Dumot C; Berhouma M; Ducray F; Armoiry X; Margier J; Guerre P; Varlet P; Meyronet D; Metellus P; Guyotat J;
    J Neurosurg; 2024 Apr; 140(4):987-1000. PubMed ID: 37856381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Aminolevulinic acid for recurrent malignant gliomas: A systematic review.
    Broekx S; Weyns F; De Vleeschouwer S
    Clin Neurol Neurosurg; 2020 Aug; 195():105913. PubMed ID: 32447151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment.
    Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R
    Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell analysis of 5-aminolevulinic acid intraoperative labeling specificity for glioblastoma.
    Liu Z; Mela A; Argenziano MG; Banu MA; Furnari J; Kotidis C; Sperring CP; Humala N; Mahajan A; Bruce JN; Canoll P; Sims PA
    J Neurosurg; 2024 Apr; 140(4):968-978. PubMed ID: 37773782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The patients' view: impact of the extent of resection, intraoperative imaging, and awake surgery on health-related quality of life in high-grade glioma patients-results of a multicenter cross-sectional study.
    Nickel K; Renovanz M; König J; Stöckelmaier L; Hickmann AK; Nadji-Ohl M; Engelke J; Weimann E; Freudenstein D; Ganslandt O; Bullinger L; Wirtz CR; Coburger J
    Neurosurg Rev; 2018 Jan; 41(1):207-219. PubMed ID: 28265818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of visible 5-ALA fluorescence and quantitative protoporphyrin IX analysis for improved surgery of suspected low-grade gliomas.
    Widhalm G; Olson J; Weller J; Bravo J; Han SJ; Phillips J; Hervey-Jumper SL; Chang SM; Roberts DW; Berger MS
    J Neurosurg; 2020 Jul; 133(1):79-88. PubMed ID: 31075771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience.
    Haider SA; Lim S; Kalkanis SN; Lee IY
    J Neurooncol; 2019 Feb; 141(3):507-515. PubMed ID: 30506501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of PpIX-fluorescence of cerebral metastases: a pilot study.
    Knipps J; Fischer I; Neumann LM; Rapp M; Dibué-Adjei M; Freiin von Saß C; Placke JM; Mijderwijk HJ; Steiger HJ; Sabel M; Cornelius JF; Kamp MA
    Clin Exp Metastasis; 2019 Oct; 36(5):467-475. PubMed ID: 31376098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?
    Hadjipanayis CG; Widhalm G; Stummer W
    Neurosurgery; 2015 Nov; 77(5):663-73. PubMed ID: 26308630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.
    Kiesel B; Mischkulnig M; Woehrer A; Martinez-Moreno M; Millesi M; Mallouhi A; Czech T; Preusser M; Hainfellner JA; Wolfsberger S; Knosp E; Widhalm G
    J Neurosurg; 2018 Aug; 129(2):341-353. PubMed ID: 29076783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of PEPT2 as an important candidate molecule in 5-ALA-mediated fluorescence-guided surgery in WHO grade II/III gliomas.
    Hou C; Yamaguchi S; Ishi Y; Terasaka S; Kobayashi H; Motegi H; Hatanaka KC; Houkin K
    J Neurooncol; 2019 Jun; 143(2):197-206. PubMed ID: 30929128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of 5-aminolevulinic acid-induced fluorescence in 55 different spinal tumors.
    Millesi M; Kiesel B; Woehrer A; Hainfellner JA; Novak K; Martínez-Moreno M; Wolfsberger S; Knosp E; Widhalm G
    Neurosurg Focus; 2014 Feb; 36(2):E11. PubMed ID: 24484249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.